| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | 0.091 | 0.6 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |